Home / Justification of Award for Low Titer Whole Blood / Document

Justification and Approval Low Titer Whole Blood Redacted

Updated

A PDF document (125 KB) attached to Justification of Award for Low Titer Whole Blood, from the Defense Health Agency (DHA).

File name: Justification and Approval Low Titer Whole Blood_Redacted.pdf

Download the full documentSee the bid

The full file is for paid members, or buy this bid alone.

Preview

CUI
Control Number: FY26-0814

Justification and Approval (J&A) for Other than Full and Open Competition Revolutionary Federal Acquisition Regulation (FAR) Overhaul (RFO) Parts 6 and 12 Implemented by Class Deviation 2026-O0017, Revision 1
1. Identification of the Agency and Contracting Activity: Defense Health Agency (DHA), DHA Contracting Activity (DHACA), Healthcare Contracting Division (HCD) Southeast. 2. Nature and/or Description of Action being Approved: The purpose of this requirement is to award a new sole source supply, Firm Fixed Price, as an individual award that requires Low Titer Whole Blood for treatment of trauma and emergent conditions. This requirement will be conducted in accordance with FAR Part 12 procedures for commercial supplies.
3. Description of Supplies/Services and Estimated Value: Naval Medical Center Camp Lejeune requires a constant supply of Low Titer Whole Blood to be utilized for the care and emergency treatment of patients within the Level II Trauma Center. Due to the emergent need for the product in certain situations, there is a requirement for the supplies to be available and delivered within 3.5 hours of the receipt of a STAT order. The award will be for a base period and four option periods.
The proposed source is Blood Connection, Inc. (Cage Code: 6ZYS6), 1099 Bracken Rd., Piedmont, SC 29673-9644.
Period
Base Period
Option Period 1
Option Period 2
Option Period 3
Option Period 4

Period of Performance or
Required Delivery Date

01 October 2026 –

30 September 2027

01 October 2027 –

30 September 2028

01 October 2028 –

30 September 2029

01 October 2029 –

30 September 2030

01 October 2030 –

30 September 2031

Estimated Value

Type of Funding
O&M
O&M
O&M
O&M
O&M

Controlled by: Defense Health Agency (DHA)
Controlled by: HCD Southeast
CUI Category(ies): Source Selection
Limited Dissemination Control: FEDCON
POC: Felicia W. Smith

CUI
Source Selection Information - See FAR 2.101 and 3.104-4

OCT 2024

CUI
Control Number: FY26-0814

Period

Period of Performance or
Required Delivery Date

Estimated Value

Total

Type of Funding

$521,250.00

4. Statutory Authority Permitting Other Than Full and Open Competition: Authority 41 USC 3304(a)(1) and FAR 6.103-1(b) the supplies required by agency are available from a limited number of responsible sources but only one can satisfy the agency requirements. 5. Rationale Justifying Use of Authority Cited: While there are other sources that provide the

The beginning of the document. Download the full file to read on.